ANI Pharmaceuticals receives FDA approval for the pre -emptive syringe of the purified curtrofin gel

Washington (DPA -AFX) – ANI Pharmaceuticals Inc. (ANIP) has announced that the US Food and Drug Administration has approved the purified cortropine gel (USP warehouse injection) (cortrofine gel) in a pre -filled syringe format. The new presentation will be available in 40 USP/0.5 ml units and 80 USP/ml units with a single dose through the cotofin gels established the specialized pharmacy network.

Prepaid syringe reduces administration stages for patients using cortrophine gel, which remains available in 5 ml and 1 ml vials.

The company mentioned that the new pre -prepaid syringe reduces the necessary stages to patients to administer corthofine gel treatment.

The company is looking forward to making available the prepared syringe of the Cortrophin gel in the second quarter of 2025, as it continues to advance our portfolio of rare diseases.